Literature DB >> 12005160

Haemodynamic limitations and exercise performance in peripheral arterial disease.

S Green1.   

Abstract

It has been frequently argued that haemodynamic limitations are poor predictors of exercise performance in people with peripheral arterial disease (PAD) and intermittent claudication. This review has tried to address this argument through a review of published data that appears to support or counterbalance it, brief consideration of some of the methodological limitations associated with these data, as well as some other considerations. The main argument rests primarily upon data about the resting ankle-brachial index (ABI) and/or blood flow after calf exercise or an ischaemic challenge; whereas the counter argument rests mainly on data about blood flow during walking or cyding exercise. Consideration of the limitations of all methods suggests that the measurement of blood flow during exercise has the greatest value in explaining differences in exercise performance amongst claudicants; whereas the other methods are relatively limited in their explanatory value. This strengthens the counter argument and undermines the main argument proposed by others. Consequently, asserting that haemodynamic limitations are poor predictors of exercise performance in claudicants is not justified in light of available evidence.

Entities:  

Mesh:

Year:  2002        PMID: 12005160     DOI: 10.1046/j.1365-2281.2002.00400.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  9 in total

1.  Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.

Authors:  Jennifer L Robbins; W Schuyler Jones; Brian D Duscha; Jason D Allen; William E Kraus; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Atorvastatin increases exercise leg blood flow in healthy adults.

Authors:  Beth A Parker; Jeffrey A Capizzi; Amanda L Augeri; Adam S Grimaldi; C Michael White; Paul D Thompson
Journal:  Atherosclerosis       Date:  2011-10-04       Impact factor: 5.162

3.  Venous occlusion plethysmography versus Doppler ultrasound in the assessment of leg blood flow during calf exercise.

Authors:  Simon Green; R Thorp; E J Reeder; J Donnelly; G Fordy
Journal:  Eur J Appl Physiol       Date:  2011-01-14       Impact factor: 3.078

Review 4.  Combined Lower Limb Revascularisation and Supervised Exercise Training for Patients with Peripheral Arterial Disease: A Systematic Review of Randomised Controlled Trials.

Authors:  Annelise L Menêses; Raphael M Ritti-Dias; Belinda Parmenter; Jonathan Golledge; Christopher D Askew
Journal:  Sports Med       Date:  2017-05       Impact factor: 11.136

5.  Supervised and home-based exercise training for patients with intermittent claudication.

Authors:  Jianxiong Wang; Shi Zhou; Roger Bronks; John Graham; Stephen Myers
Journal:  Int J Angiol       Date:  2008

6.  Venous occlusion plethysmography vs. Doppler ultrasound in the assessment of leg blood flow kinetics during different intensities of calf exercise.

Authors:  Elaine Murphy; Joel Rocha; Norita Gildea; Simon Green; Mikel Egaña
Journal:  Eur J Appl Physiol       Date:  2017-11-30       Impact factor: 3.078

7.  Effect of type 2 diabetes mellitus on exercise intolerance and the physiological responses to exercise in peripheral arterial disease.

Authors:  S Green; C D Askew; P J Walker
Journal:  Diabetologia       Date:  2007-01-20       Impact factor: 10.122

8.  Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease.

Authors:  Timothy A Bauer; Eric P Brass; Thomas J Barstow; William R Hiatt
Journal:  Eur J Appl Physiol       Date:  2007-02-20       Impact factor: 3.346

Review 9.  Ankle brachial pressure index (ABPI): An update for practitioners.

Authors:  Mo Al-Qaisi; David M Nott; David H King; Sam Kaddoura
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.